Concall AI
Call held 14 Aug 2025
Management summary
Max Healthcare delivered strong Q1 FY26 performance with robust growth metrics, extending its growth streak to 19 consecutive quarters. The results demonstrate successful execution of acquisition integration and expansion strategy.
19th consecutive quarter of year-on-year growth
Revenue growth of 27% YoY
Operating EBITDA growth of 23% YoY
Strong performance driven by successful integration of recent acquisitions
Continued expansion and operational excellence
Q1 FY27: revenue up 16.7%, net profit up 4.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,707 | 1,868 | 1,910 | 2,028 | 2,135 +25% | 2,068 +11% | 2,143 +12% | 2,366 +17% |
| EBITDA | 451 | 499 | 512 | 523 | 575 +27% | 538 +8% | 606 +18% | 598 +14% |
| Net profit | 282 | 239 | 319 | 308 | 491 +74% | 301 +26% | 342 +7% | 323 +5% |
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Max Healthcare achieved its 19th consecutive quarter of YoY growth with strong 27% revenue growth and 23% EBITDA growth, demonstrating sustained operational excellence and successful strategic execution.
Performance was driven by successful integration of recent hospital acquisitions, showing the company's ability to effectively scale and integrate new assets into its network.
